TRUXIMA
Google image searchProduct monograph
Active ingredient
rituximab, 500 MG/50 ML
DIN: 02478390
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-DOSE VIAL - 10 MG/ML
Schedule: Prescription / Schedule D
Company: CELLTRION INC.
Date: 22-AUG-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FA — CD20 (Clusters of Differentiation 20) inhibitors (ATC, ATC/DDD)
- L01FA01 — RITUXIMAB (ATC/DDD)
Reference brand drug: Rituxan, Riximyo, Ruxience, Truxima
